ZANUBRUTINIB

4539 reported adverse events

Drug classes: Kinase Inhibitor [EPC]

These side effects are most commonly reported by patients taking ZANUBRUTINIB:

# Side effect Count
0 OFF LABEL USE 585
1 DISEASE PROGRESSION 318
2 MYELOSUPPRESSION 254
3 FATIGUE 249
4 ANAEMIA 247
5 WHITE BLOOD CELL COUNT DECREASED 247
6 CONTUSION 241
7 PLATELET COUNT DECREASED 219
8 RASH 212
9 DEATH 211
See all common reactions for ZANUBRUTINIB

ZANUBRUTINIB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CYTOKINE INCREASED 56 0.4148
1 TYROSINE KINASE MUTATION 5 0.2000
2 FOLLICULAR LYMPHOMA RECURRENT 14 0.1750
3 MARGINAL ZONE LYMPHOMA RECURRENT 5 0.1042
4 ACQUIRED C1 INHIBITOR DEFICIENCY 2 0.0952
5 MANTLE CELL LYMPHOMA RECURRENT 34 0.0782
6 LYMPHOMA TRANSFORMATION 24 0.0667
7 KARYOTYPE ANALYSIS ABNORMAL 6 0.0550
8 UVEAL MELANOMA 3 0.0536
9 BING-NEEL SYNDROME 2 0.0513
See all enriched reactions for ZANUBRUTINIB